Arca Biopharma (ABIO)
NASDAQ:ABIO

Arca Biopharma (ABIO) Stock Investors

471 Followers
Based on 748,626 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ABIO
On average, investors allocate 0.00% of their portfolios to ABIO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,626 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ABIO

1.7%
Last 7
Days
0.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ABIO, out of 748,626 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ABIO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$3.28
Based on the activity of 14,213 investors who made their portfolios public
The table shows changes in ABIO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ABIO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
APA
4.94%
-1.72%
-5.01%
11.61B
Energy
Assertio Therapeutics
2.87%
-1.60%
-5.40%
139.83M
Healthcare
GE Aerospace
5.27%
+1.62%
+3.04%
178.55B
Industrials
Plug Power
5.00%
-1.23%
-3.38%
1.91B
Industrials
Riot Platforms
5.10%
-0.52%
+0.86%
3.10B
Financial
DraftKings
5.77%
-1.15%
-1.80%
31.40B
Consumer Cyclical
Blink Charging Co
5.23%
-1.38%
-4.59%
329.45M
Industrials
Bristol-Myers Squibb
3.29%
-1.22%
+0.46%
91.77B
Healthcare
AMC Entertainment
5.74%
-1.22%
-4.08%
1.52B
Communication Services
Marathon Digital Holdings
5.54%
-1.09%
+0.30%
5.54B
Financial
Based on the activity of 748,626 active portfolios
Open your Smart Portfolio

ABIO Investor Analysis

ABIO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.5%
of ABIO holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
ABIO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
43.8%
of ABIO holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
ABIO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.8%
of ABIO holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of ABIO stock investors
See who invests in ABIO according to age group and performance.

FAQ

How many retail Investors hold ABIO?
<0.1% of TipRanks' retail investors hold ABIO in their portfolios.
    What is ABIO Investor Sentiment?
    ABIO’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ABIO in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of ABIO in the last 7 days.
        What percentage of retail investors changed their holding of ABIO in the last 30 days?
        ▼ 0.5% of TipRanks' retail investors changed their holding of ABIO in the last 30 days.
          What is the average age of retail investors who hold ABIO?
          The average age of ABIO Holders is over 55.
            What other stocks have ABIO investors also bought?
            ABIO Investors also bought APA, ASRT, GE, PLUG, RIOT, DKNG, BLNK, BMY, AMC, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BAXBaxter International
              CRLCharles River Labs
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis